1. Ajayi-Smith, A.F., van der Watt, P.J. and Leaner, V.D., 2019. Interfering with nuclear transport as a means of interrupting transcription factor activity in cancer. Critical Reviews™ in Eukaryotic Gene Expression, 29(5).
2. Allanson, E.R. et al., 2019. Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis. PloS one, 14(7), p.e0217775.
3. Antel, K. et al. 2019. The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting. BMC cancer, 19(1), pp.1-11.
4. Berg, C. et al., 2019. Modulation of the solubility properties of arene ruthenium complexes bearing stannyl ligands as potential anti-cancer agents. Journal of Organometallic Chemistry, 891, pp.12-19.
5. Bhatla, N. et al., 2019. Revised FIGO staging for carcinoma of the cervix uteri. International Journal of Gynecology & Obstetrics, 145(1), pp.129-135.
6. Bleloch, J.S. et al., 2019. The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells. Cell death discovery, 5(1), pp.1-16.
7. Blumenthal, M.J. et al., 2019. The Contribution of Kaposi’s Sarcoma–Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus–Infected Patients Being Investigated for Tuberculosis in South Africa. The Journal of infectious diseases, 220(5), pp.841-851.
8. Cairncross, L. et al., 2019. Expanding breast cancer care through partnerships and innovation: experience from a South African public hospital. South African Health Review, 2019(1), pp.105-113.
9. Cerci, J.J. et al., 2019. Is true whole-body 18F-FDG PET/CT required in pediatric lymphoma? An IAEA multicenter prospective study. Journal of Nuclear Medicine, 60(8), pp.1087-1093.
10. Cervenka, B. et al., 2019. Oral cavity cancer management guidelines for low‐resource regions. Head & neck, 41(3), pp.799-812.
11. Chambuso, R. et al., 2019. Human Leukocyte Antigen (HLA) Class II -DRB1 and -DQB1 Alleles and the Association with Cervical Cancer in HIV/HPV Co-Infected Women in South Africa. Journal of Cancer. 2019 May 20;10(10):2145-2152.
12. Chambuso, R. et al., 2019. Investigation of cervical tumor biopsies for chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV co-infected women. Frontiers in oncology, 9, p.951.
13. Chen, W.C. et al., 2019. Association of genetic variants in CHEK2 with oesophageal squamous cell carcinoma in the South African Black population. Carcinogenesis, 40(4), pp.513-520.
14. Chiesa‐Estomba, C.M. et al., 2019. Systematic review of international guidelines for perioperative antibiotic prophylaxis in Head & Neck Surgery. A YO‐IFOS Head & Neck Study Group Position Paper. Head & neck, 41(9), pp.3434-3456.
15. Chimusa, E.R., Beighton, P., Kumuthini, J. & Ramesar, R.S., 2019. Detecting genetic modifiers of spondyloepimetaphyseal dysplasia with joint laxity in the Caucasian Afrikaner community. Human molecular genetics, 28(7), pp.1053-1063.
16. Coetzee, E. & Malaka, S., 2019. Malignant neuroendocrine tumour in an adult female diagnosed with Currarino syndrome. South African Journal of Surgery, 57(4), pp.9-13.
17. Cohen, P.A., Jhingran, A., Oaknin, A. & Denny, L., 2019. Cervical cancer. The Lancet, 393(10167), pp.169-182.
18. Dalvie, S., 2019. Head and neck cancer in Africa. SA Journal of Oncology, 3(1), pp.1-4.
19. Davis, K., Roden, L.C., Leaner, V.D. & van der Watt, P.J., 2019. The tumour suppressing role of the circadian clock. IUBMB life, 71(7), pp.771-780.
20. De Oliveira T. et al., 2019. Loss of Stat6 affects chromatin condensation in intestinal epithelial cells causing diverse outcome in murine models of inflammation-associated and sporadic colon carcinogenesis. Oncogene. 38(11): pp.1787-1801
21. Dhokotera, T. et al., 2019. The burden of cancers associated with HIV in the South African public health sector, 2004–2014: a record linkage study. Infectious agents and cancer, 14(1), pp.1-12.
22. Dzobo, K., 2019. Epigenomics-guided drug development: recent advances in solving the cancer treatment “jigsaw puzzle”. Omics: a journal of integrative biology, 23(2), pp.70-85.
23. Dzobo, K., Thomford, N.E. & Senthebane, D.A., 2019. Targeting the versatile Wnt/β-catenin pathway in cancer biology and therapeutics: from concept to actionable strategy. Omics: a journal of integrative biology, 23(11), pp.517-538.
24. Edge, J., Parker, M., Maliepaard, M. & Ung, O., 2019. Lymph node harvest in breast cancer patients with and without preoperative scintigraphy. South African Journal of Surgery, 57(1), pp.7-10.
25. El Rassi, E. et al., 2019, July. Development of the international orbital Cavernous Hemangioma Exclusively Endonasal Resection (CHEER) staging system. In International forum of allergy & rhinology (Vol. 9, No. 7, pp. 804-812).
26. Engstrand, J. et al., 2019. Synchronous and metachronous liver metastases in patients with colorectal cancer—towards a clinically relevant definition. World journal of surgical oncology, 17(1), pp.1-10.
27. Fagan, J.J. et al., 2019. African head and neck fellowships: a model for a sustainable impact on head and neck cancer care in developing countries. Head & neck, 41(6), pp.1824-1829.
28. Fagan, J.J., 2019. Priority setting in otolaryngology in under resourced settings: practical and ethical dilemma. Current opinion in otolaryngology & head and neck surgery, 27(3), pp.191-192.
29. Fagan, J.J., Chaturvedi, P. & Kowalski, L.P., 2019. Treatment options for hypopharyngeal cancer in developing countries in Africa/South America/Asia. In Hypopharyngeal Cancer (Vol. 83, pp. 159-166). Karger Publishers.
30. Ferndale, L., Sartorius, B., Aldous, C. & Thomson, S.R., 2019. Oesophageal cancer in Area 2 of Kwazulu-Natal: predictors of late presentation. South African Journal of Surgery, 57(2), pp.3-9.
31. Fish, M. et al., 2019. POETIC (Program for Enhanced Training in Cancer): an initial experience of supporting capacity building for oncology training in sub‐Saharan Africa. The oncologist, 24(12), p.1557.
32. Gabriel, I.O. & Mayers, P.M., 2019. Effects of a psychosocial intervention on the quality of life of primary caregivers of women with breast cancer. European journal of oncology nursing, 38, pp.85-91.
33. Gerber, E. et al., 2019. Accuracy of plain radiographs in diagnosing biopsy-proven malignant bone lesions         . SA journal of radiology, 23(1), pp.1-7.
34. Githaiga, J.N. et al., 2019. Symptom awareness measures for breast and cervical cancer in Sub-Saharan Africa: A scoping review. South African Journal of Oncology, 3(0), a78.
35. Grant, K.A. et al., 2019. Reclassification of early stage breast cancer into treatment groups by combining the use of immunohistochemistry and microarray analysis. South African Journal of Science, 115(3-4), pp.1-6.
36. Grobbelaar, S. et el., 2019.  Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives.  South African Medical Journal, 109(8b), pp.46-52.
37. Gustavsson, I. et al., 2019. Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening. Virology journal, 16(1), pp.1-7.
38. Hess, C.B. et al., 2019. The Pediatric Radiation Oncology Society Working Group on Low- and Middle-Income Countries (PROS-LMIC) Strategic Plan to Advance Care, Education, and Research. International Journal of Radiation Oncology Biology Physics, 105(4), pp.913.
39. Hilton, T.L., Wiese, K.R., Hosking, K.V. & Hoffman, E.B., 2019. Proximal fibular resections for primary bone tumours: oncological and functional results of a case series. SA Orthopaedic Journal, 18(2), pp.44-48.
40. Hsiao, E.C. et al., 2019. Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP). British journal of clinical pharmacology, 85(6), pp.1199-1207.
41. Hussain, A.F. et al., 2019. One step site-specific antibody fragment conjugation using SNAP tag technology. Nature Protocols, 14, pp.3101-3125.
42. Jenkins, N., Louw, V. & Opie, J.J., 2019.  Images in Hematology: Massive megakaryocyte clustering in triple-negative primary myelofibrosis associated with an unusual cytogenetic aberration.  British Journal of Haematology, 186(4), pp.510.
43. John, J., Locketz, M., Lazarus, J. & Sinha, S., 2019. Papillary renal cell carcinoma presenting as a renal abscess. South African Journal of Surgery, 57(2), pp.66-67.
44. Jonas, E., 2019. Treatment of hepatocellular cancer in sub-Saharan Africa: balancing ideals, realities and challenges. South African Journal of Surgery, 57(3), pp.2-4.
45. Kaschula, C.H. et al., 2019. The garlic compound ajoene covalently binds vimentin, disrupts the vimentin network and exerts anti-metastatic activity in cancer cells. BMC cancer, 19(1), pp.1-16.
46. Katsidzira, L. et al., 2019. A case-control study of risk factors for colorectal cancer in an African population. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP), 28(3), p.145.
47. Katsidzira, L. et al., 2019. Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases. Plos one, 14(10), p.e0224023.
48. Kengne, A.P. and other GBD 2017 Pancreatic Cancer Collaborators., 2019. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019 Dec;4(12):934-947.
49. Khan, S.F. et al., 2019. The roles and regulation of TBX3 in development and disease, Gene, 726, pp. 144223.
50. Kingswood, J.C. et al., 2019. Renal angiomyolipoma in patients with tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increase disease Awareness. Nephrology Dialysis Transplantation, 34(3), pp.502-508.
51. Kisling, K. et al., 2019. Fully automatic treatment planning for external-beam radiation therapy of locally advanced cervical cancer: a tool for low-resource clinics. Journal of global oncology, 5, pp.1-9.
52. Kisling, K. et al., 2019. A risk assessment of automated treatment planning and recommendations for clinical deployment. Medical Physics, 46(6).
53. Kisling, K., Zhang, L., Shaitelman, S.F. & Anderson, D., 2019. Automated treatment planning of postmastectomy radiotherapy. Med Phys. 46 (9), pp.2567-2574.
54. Koegelenberg, C.F. et al., 2019. Recommendations for lung cancer screening in Southern Africa. Journal of thoracic disease, 11(9), p.3696.
55. Kowlessur, B. et al., 2019. Validating the European randomised study for screening of prostate cancer (ERSPC) risk calculator in a contemporary South African cohort. World journal of urology, pp.1-8.
56. Kramer, N., Ramjith, J. & Shamley, D., 2019. Prevalence of shoulder morbidity after treatment for breast Cancer in South Africa. Supportive Care in Cancer, 27(7), pp.2591-2598.
57. Liebenberg, L.J. et al., 2019. HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nature communications, 10(1), pp.1-12.
58. Lin, C. et al., 2019. Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis. The Lancet Infectious Diseases, 19(8), pp.880-891.
59. Lu, Y. et al., 2019. Circulation patterns and seed-soil compatibility factors cooperate to cause cancer organ-specific metastasis     . Experimental cell research, 375(1), pp.62-72.
60. Lubbe, D. et al., 2019. Transorbital endoscopic surgery. Current Otorhinolaryngology Reports, 7(2), pp.173-180.
61. Lubbe, D.E., Mankahla, N., Carrara, H. & Semple, P., 2019. Surgical intervention for binocular blindness in pituitary apoplexy. Interdisciplinary Neurosurgery, 18, p.100490.
62. Ludmir, E. et al., 2019. Assembling the Brain Trust: The Multidisciplinary Imperative in Neuro-Oncology. Nature reviews in Clinical Oncology, 16(8), pp.521-522.
63. Mafu, T.S., September, A.V. & Shamley, D., 2019. KDR inferred haplotype is associated with upper limb dysfunction in breast cancer survivors of mixed ancestry. Cancer management and research, 11, p.3829.
64. Mapekula, L., Ramorola, B.R., Hoosen, T.G. & Mowla, S., 2019. The interplay between viruses & host microRNAs in cancer–an emerging role for HIV in oncogenesis. Critical reviews in oncology/hematology, 137, pp.108-114.
65. Marques, R. et al., 2019. The TOSCA Registry for Tuberous Sclerosis—Lessons Learnt for Future Registry Development in Rare and Complex Diseases. Frontiers in neurology, 10, p.1182.
66. Marques, R. et al., 2019. Treatment patterns and use of resources in patients with tuberous sclerosis complex: insights from the TOSCA registry. Frontiers in neurology, 10, p.1144.
67. Matejcic, M., Mathew, C.G. & Parker, M.I., 2019. The Relationship Between Environmental Exposure and Genetic Architecture of the 2q33 Locus With Esophageal Cancer in South Africa. Frontiers in genetics, 10, p.406.
68. McGuire, J., Lentin, R., DeVilliers, A. & Fagan, J., 2019. Pharyngoesophageal spasm after total laryngectomy: A clinically guided technique for injection. East and Central African Journal of Surgery, 24(3).
69. McGuire, J.K. et al., 2019. Does Thyroid Gland Preserving Total Laryngectomy Affect Oncological Control in Laryngeal Carcinoma? Laryngoscope, 130(6):1465-1469.
70. Montagna, G. et al., 2019. How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2). The Breast, 43, pp.18-21.
71. Moodley, J. et al., 2019. Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer. PloS one, 14(8), p.e0220545.
72. Moodley, J. et al., 2019. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions. BMC women's health, 19(1), pp.1-10.
73. Mortimer, T.L., Mabin, T. & Engelbrecht, A.M., 2019. Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting. Future Oncology, 15(9), pp.1035-1049.
74. Mungra, N. et al., 2019. Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells. Oncotarget, 10(8), pp.897-915.
75. Nachreiner, I. et al., 2019. Elimination of HER3‑expressing breast cancer cells using aptamer‑siRNA chimeras. Experimental and therapeutic medicine, 18(4), pp.2401-2412.
76. Nel, D., Omar, M., Chinnery, G. & Jonas, E., 2019. Disparity in oesophageal cancer management in South Africa: A comparison between two tertiary centres with special focus on the palliation of dysphagia. South African Journal of Surgery, 57(2), pp.10-15.
77. Ngcobo, N.J., Burnett, R.J., Cooper, S. & Wiysonge, C.S., 2019. Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda. South African Medical Journal, 109(1), pp.13-15.
78. O'Brien, V. et al., 2019. Palliative care made visible: Developing a rural model for the Western Cape Province, South Africa. African Journal of Primary Health Care and Family Medicine. 31;11(1):e1-e11.
79. Omar, R. et al., 2019. COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration. Cancer letters, 459, pp.227-239.
80. Omitola, O.G. et al., 2019. Descriptive epidemiology of salivary gland neoplasms in Nigeria: An AOPRC multicenter tertiary hospital study. Oral Disease. 25(1):142-149.
81. Onywera, H. et al., 2019. The cervical microbiota in reproductive-age South African women with and without human papillomavirus infection. Papillomavirus research, 7, pp.154-163.
82. Paccez, J.D. et al., 2019. Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl. Oncogenesis, 8(3), pp.1-14.
83. Padayachee, E.R. et al., 2019. Applications of SNAP-tag technology in skin cancer therapy. Health Science Reports, 2(2), e103.
84. Pickard, H.D.P. et al., 2019. The management of desmoid tumours at Groote Schuur Hospital retrospective review of current practice. South African Journal of Oncology, 3, a68.
85. Plessis, J., Stones, D. & Meiring M., 2019. Family experiences of oncological palliative and supportive care in children: can we do better? International Journal of Palliative Nursing. 2;25(9):421-430.
86. Rayne, S. et al., 2019. Delay to diagnosis and breast cancer stage in an urban South African breast clinic. South African Medical Journal. 26;109(3): pp. 159-163.
87. Rayne, S. et al., 2019. The effect of beliefs about breast cancer on stage and delay to presentation: results from a prospective study in urban South Africa. South African Journal of Surgery, 57(1), pp.12-18.
88. Rayne, S. et al., 2019. Unraveling the South African Breast Cancer Story: The Relationship of Patients, Delay to Diagnosis, and Tumor Biology With Stage at Presentation in an Urban Setting. Journal of Surgical Research, 235, pp.181-189.
89. Safiri, S. et al., 2019. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The lancet Gastroenterology & hepatology, 4(12), pp.913-933.
90. Saidu, R. et al., 2019. South African women’s perspectives on self-sampling for cervical cancer screening: A mixed-methods study. South African Medical Journal, 109(1), pp.47-52.
91. Scott, A.J. et al., 2019. Quality of life after total laryngectomy: evaluating the effect of socioeconomic status. The Journal of Laryngology & Otology, 133(2), pp.129-134.
92. Sinkala, M., Mulder, N. & Martin, D.P., 2019. Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers. Communications biology, 2(1), pp.1-14.
93. Sluis Cremer, T., Hosking, Κ., Held, M. & Hilton, T.L., 2019. Minimally invasive CT-guided excision of osteoid osteoma and other small benign bone tumours: a single centre case series in South Africa. SA Orthopaedic Journal, 18(1), pp.26-32.
94. Soyele, O.O. et al., 2019. A multi-centre evaluation of malignant odontogenic tumours in Nigeria. The Pan African Medical Journal, 33.
95. Swart, L., Novitzky, N., Mohamed, Z. & Opie, J., 2019. Hodgkin lymphoma at Groote Schuur Hospital, South Africa: The effect of HIV and bone marrow infiltration. Annals of hematology, 98(2), pp.381-389.
96. Tan, S., Khumalo, N. & Bayat, A., 2019. Understanding keloid pathobiology from a quasi-neoplastic perspective: less of a scar and more of a chronic inflammatory disease with cancer-like tendencies. Frontiers in immunology, 10, p.1810.
97. Tomasicchio, M. et al., 2019. An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells. Cancer Immunology, Immunotherapy, 68(1), pp.71-83.
98. Ujma, S. et al., 2019. Surfactant protein a impairs genital HPV16 pseudovirus infection by innate immune cell activation in a murine model. Pathogens, 8(4), p.288.
99. Van Heerden, J. et al., 2019. Overall survival for neuroblastoma in South Africa between 2000 and 2014. Pediatric Blood and Cancer. 66(11):e27944.
100. van Schalkwyk, C., Moodley, J., Welte, A. & Johnson, L.F., 2019. Are associations between HIV and human papillomavirus transmission due to behavioural confounding or biological effects?. Sexually transmitted infections, 95(2), pp.122-128.
101. van Schalkwyk, C., Moodley, J., Welte, A. & Johnson, L.F., 2019. Estimated impact of human papillomavirus vaccines on infection burden: The effect of structural assumptions. Vaccine, 37(36), pp.5460-5465.
102. Vaughan, C.L., 2019. Novel imaging approaches to screen for breast cancer: Recent advances and future prospects. Medical engineering & physics, 72, pp.27-37.
103. Vorster, M. et al., 2019. South African guidelines for receptor radioligand therapy (RLT) with Lu-177-PSMA in prostate cancer. South African Journal of Surgery, 57(4), pp.45-51.
104. Wiyeh, A.B. et al. 2019. Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa. Vaccine, 37(43), pp.6317-6323.